Up in Your Business with Kris Frieswick

 
  

Genzyme's woes
Sept. 27, 2010

Genzyme, the largest biotech company in the Boston-area, has been hit by hard times recently. A virus contaminated the biotech giant's Allston plant and resulted in a $175 million fine from the FDA. Now, a French drug company is interested in purchasing Genzyme. Business contributor Kris Frieswick joins Emily to gauge the impact this is having on Genzyme and biotech in Boston.

Support for WGBH is provided by:
Become a WGBH sponsor
Sign Up

Subscribe to WGBH News Emails
 

   

 

ABOUT UP IN YOUR BUSINESS WITH KRIS FRIESWICK

Business contributor Kris Frieswick's insights on the latest business news.

Turesday, July 6, 2010

7:00 pm, Ch. 2, WGBH

 House-swapping: the alternative to hotels


Kris Frieswick Twice a month, Greater Boston’s Up In Your Business contributor Kris Frieswick offers her advice on making smart financial decisions in an uncertain economy. Kris is an award-winning business reporter whose works have appeared in Boston Magazine, the Economist and Redbook Magazine. She is also the author of The Cheap Bastard’s Guide to Boston. From credit card rules to jobs to retirement plans, Kris covers it all.

 

Stay up-to-date with Kris!

 

on Twitter

 

 

on Greater Boston

 

myWGBH

Up in Your Business with Kris Frieswick Showtimes

Forgot your my WGBH Password?

Not a problem. Just enter the username you used to register below.


Or CREATE A NEW ACCOUNT

Forgot your my WGBH Password?

Instructions on how to reset your Password have been sent.
Check your email to continue.

Or CREATE A NEW ACCOUNT

Forgot your my WGBH Username?

Not a problem. Just enter the email address you used to register below.


Or CREATE A NEW ACCOUNT

Forgot your my WGBH Username?

Instructions on how to reset your Username have been sent.
Check your email to continue.

Or CREATE A NEW ACCOUNT

Register for myWGBH